<DOC>
	<DOCNO>NCT00803543</DOCNO>
	<brief_summary>The purpose study determine common herpes among person HIV know valacyclovir reduces outbreaks herpes , amount HIV blood , amount HSV bodily secretion .</brief_summary>
	<brief_title>Seroprevalence HSV-2 HIV Infected Subjects Effect Daily Valacyclovir Reduction HSV-2 Recurrence Viral Shedding</brief_title>
	<detailed_description>Most people herpes infection know infection . HSV infection often occur area around mouth genital tract . HSV Type 1 ( HSV-1 ) usually cause `` cold sore '' fever blister HSV Type 2 ( HSV-2 ) usually cause lesion genital rectal area . However , HSV-1 sometimes cause genital herpes HSV-2 cause oral lesion ( acquire oral-genital sex ) . Herpes Simplex transmit contact someone shed virus either mouth genital tract , usually kiss sexual intercourse . While contact active sore cause transmission , contact saliva genital secretion infect , even person obvious sore . This call asymptomatic shedding HSV . Once acquire , virus ability remain inactive nervous system area mouth genital region . Persons HIV HSV-2 often shed virus . We know person HSV-2 tend increased amount HIV blood well . Recently , research study find take medicine daily prevent asymptomatic HSV-2 shed reduce amount HIV find blood genital secretion . This study seek determine common herpes among person HIV know valacyclovir ( FDA approve drug ) reduce outbreaks herpes , amount HIV blood , amount HSV bodily secretion .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>19 year old HSV2 seropositive determine HerpeSelect2 ELISA Documented HIV1 seropositive Currently receive HAART 3 month longer CD4 count 350 great Women child bear potential must agree use acceptable contraceptive measure entire conduct study . Acceptable contraceptive method include one following : oral hormonal contraceptive , injectable hormonal contraceptive , transdermal hormonal contraceptive , IUD , diaphragm cervical cap . Willing able provide write informed consent , undergo clinical evaluation , take study drug direct History symptomatic genital herpes , lesion symptoms consistent genital herpes , recurrent undiagnosed symptom consistent genital herpes . Known history adverse reaction acyclovir , valacyclovir , famciclovir . Planned open label use acyclovir , valacyclovir , ganciclovir , valganciclovir , famciclovir , cidofovir , foscarnet oral herpes herpes viral infection . Medical history seizure Renal insufficiency , define serum creatinine great 1.5 mg/dl AST ALT 5 time up limit normal History thrombotic microangiopathy For woman , pregnancy confirm urine serum pregnancy test . Any condition , opinion principal investigator , may compromise subject 's ability follow study procedure complete study . Participants active bacterial STDs may treat eligible enrollment 14 day STD therapy discontinue symptom resolve .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>HSV-2</keyword>
	<keyword>Herpes Simplex</keyword>
	<keyword>HSV Type 2</keyword>
	<keyword>HIV</keyword>
	<keyword>HIV/HSV</keyword>
	<keyword>treatment experience</keyword>
</DOC>